$1.67
-0.08-4.57%
Last update: Nov 10, 10:40 AM
Niki BioSolutions Inc
NIKINASDAQ
Niki BioSolutions fell 87.5% from $14.00 to $1.75, behind the S&P 500's +10.5%. Its worst day was Oct 12 (−22.7%), and its low came Nov 5 at $1.52.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Niki BioSolutions closed at its highest level of the year, 15.7% above where the year started.
+3.8% · S&P 500 +0.4%
Niki BioSolutions shares rose 16.2%, while the S&P 500 fell 0.3%.
+16.2% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
Niki BioSolutions shares rose 19.3%, while the S&P 500 fell 0.5%.
+19.3% · S&P 500 −0.5%
Niki BioSolutions shares rose 19.8%, while the S&P 500 rose 0.8%.
+19.8% · S&P 500 +0.8%
Niki BioSolutions shares rose 22.9%, while the S&P 500 rose 0.2%.
+22.9% · S&P 500 +0.2%
Niki BioSolutions shares fell 19.3%, while the S&P 500 fell 1.6%.
−19.3% · S&P 500 −1.6%
Niki BioSolutions shares rose 26.1%, while the S&P 500 fell 0.2%.
+26.1%, the year's best day · S&P 500 −0.2%
Niki BioSolutions shares rose 16.0%, while the S&P 500 rose 1.7%.
+16.0% · S&P 500 +1.7%
Niki BioSolutions, Inc., a Delaware corporation (the "Company," "Niki," "we," "our," or "us"), has entered into an at-the-market issuance sales agreement, dated October 9, 2026
−22.7%, the year's worst day · S&P 500 −0.1%
Where it ended: a close of $1.75 on Nov 9, 2026. Up next: H1 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All NIKI earningsNothing in the past 12 months.
All NIKI analyst actionsNothing in the past 12 months.
All NIKI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NIKI and SPY from Benzinga historical bars. Not investment advice.
